R. Lutter (Amsterdam, The Netherlands), B. Balbi (Pavia, Italy)
Increased exhaled 8-isoprostane in aspirin-sensitive asthma
A. Antczak, S. A. Kharitonov, P. Montuschi, P. Gorski, P. J. Barnes (Lodz, Poland; London, United Kingdom)
|  |
Altered platelet function in asthmatic patients
S. Yavuzer, D. Tekin, G. Ersoz, B. A. Sin, Z. Misirligil (Ankara, Turkey)
| |
An investigation of apoptotic eosinophil numbers in induced sputum: is there an association with asthma severity?
G. M. Walsh, C. J. Duncan, M. G. Blaylock, J. G. Douglas (Aberdeen, United Kingdom)
| |
Oxidative stress in infectious exacerbation of asthma
A. Antczak, A. Rul, P. Górski (Lodz, Poland)
| |
Increased concentration of hydrogen peroxide (H2O2) in expired breath condensate of patients with lung cancer and stable chronic obstructive pulmonary disease
M. Zieba, S. Kwiatkowska, K. Tymiñska, I. Grzelewska-Rzymowska, D. Nowak, U. Szkudlarek (Lodz, Poland)
| |
pH in expired breath condensate of patients with inflammatory airway diseases
K. Kostikas, G. Papatheodorou, K. Ganas, K. Psathakis, P. Panagou, S. Loukides (Athens, Greece)
| |
8-isoprostane in breath condensate in patients with exacerbation of COPD
W. Biernacki, N. Isola, S. A. Kharitonov, P. J. Barnes (London, United Kingdom)
| |
Leukotriene B4 in breath condensate in patients with exacerbation of COPD
W. Biernacki, N. Isola, S. A. Kharitonov, P. J. Barnes (London, United Kingdom)
| |
Increased exhaled cysteinyl-leukotrienes, leukotriene B4 and 8-isoprostane in exacerbation of COPD
A. Antczak, P. Gorski (Lodz, Poland)
| |
Exhaled 8-isoprostane, a marker of oxidative stress, is increased in patients with bronchiectasis
N. Isola, Z. Csoma, S. A. Kharitonov, R. Wilson, P. J. Barnes (London, United Kingdom)
| |
Increased serum α1-antitrypsin level in COPD patients with predominant lung emphysema
K. Malakauskas, R. Sakalauskas, V. Dudzevicius, R. Planciuniene (Kaunas, Lithuania)
| |
Role of antioxidant in patients with COPD
J. L. Videnovic-Ivanov, J. A. Djordjevic, V. M. Vucinic-Mihajlovic (Belgrade, Yugoslavia)
| |
Antioxidant defence in acute exacerbation of COPD
C. Luyten, F. J. van Overveld, K. Vandekerckhove, W. A. De Backer (Antwerp, Belgium)
| |
Matrix metalloproteinases and lung disease severity in chronic obstructive pulmonary disease (COPD)
V. Keatings, C. M. Ryan, K. MacMahon, D. McGrath, M. X. FitzGerald, C. M. O'Connor (Dublin, Ireland)
| |
Inhalation of α 1-protease inhibitor (α 1-Pi): influence on the protease-antiprotease balance in the epithelial lining fluid (ELF) of patients with α 1-Pi deficiency
M. Wencker, C. Vogelmeier, M. Maas-Enriquez, H. Beckmann, N. Konietzko (Essen, Munich, Leverkusen, Germany)
| |
Effect of danazol on acute phase reactants in patients with PiM, PiMZ and PiZ phenotypes for alpha-1-antitrypsin deficiency
P. A. Dawkins, A. T. Hill, D. L. Bayley, R. A. Stockley (Birmingham, United Kingdom)
| |
Airway inflammation persists after smoking cessation in chronic obstructive pulmonary disease (COPD)
E. Gamble, K. Hattotuwa, J. Zhu, S. Majumdar, T. Ansari, T. Tat, N. C. Barnes, P. K. Jeffery (London, United Kingdom)
| |
Correlation between a polymorphism in the promotor region of MMP3 (Stromelisyn-1) and the clinical-functional history in COPD patients
P. Santus, M. L. Biondi, O. Turri, S. Leviti, F. Castagna, F. Casanova, S. Centanni (Milan, Italy)
| |
Collagen content in human pulmonary emphysema
M. L. Rubio, M. C. Martin-Mosquero, M. Ortega, N. Gonzalez-Mangado, G. Peces-Barba (Madrid, Spain)
| |
The relationship between inflammatory cells and structural changes in ”healthy“ smokers and never smokers. A biopsy study
K. Amin, A. Ekberg-Jansson, C. G. Löfdahl, P. Venge (Uppsala, Gothenberg, Lund, Sweden)
| |